IMP3是血管内大B细胞淋巴瘤的高敏感标志物:88例152份标本的免疫组化分析
本研究评估IMP3免疫组化在血管内大B细胞淋巴瘤(IVLBCL)诊断中的价值,对88例患者的152份病理标本(111份IVLBCL阳性、41份阴性)进行IMP3及IMP3/PAX5双染,并以40份非IVLBCL标本为阴性对照。结果显示所有111份IVLBCL标本均IMP3阳性,41份原诊断阴性标本中11份检出IMP3/PAX5双阳性细胞,提示IMP3是IVLBCL的高敏感标志物。
要点
- IMP3免疫组化对IVLBCL诊断具有高敏感性,所有111份IVLBCL标本均阳性。
- IMP3/PAX5双染有助于识别原诊断阴性标本中疑似IVLBCL的细胞。
- 阴性对照中仅2份检出非生发中心B细胞IMP3阳性,无血管内阳性B细胞。
核心结论
- IMP3免疫组化是IVLBCL的高敏感标志物,可作为诊断的有用辅助手段。
研究设计与样本
- 回顾性分析88例IVLBCL患者的152份病理标本(111份阳性、41份阴性),并进行IMP3和IMP3/PAX5染色。
- 阴性对照为38例无IVLBCL或其他B细胞淋巴瘤患者的40份标本,包括31份疑似恶性良性标本、7例阑尾炎伴血管内和/或淋巴管内淋巴增殖、2例血管内NK/T细胞淋巴瘤。
主要发现
- 所有111份IVLBCL病理标本均对IMP3和IMP3/PAX5呈阳性。
- 41份原诊断IVLBCL阴性标本中,11份显示IMP3/PAX5双阳性细胞,提示怀疑IVLBCL。
- 40份阴性对照中仅2份检出IMP3阳性的非生发中心B细胞(P = 0.0131),未发现血管内IMP3阳性B细胞可疑IVLBCL。
关键数值与推荐
- 所有单核细胞胞质染色视为IMP3表达阳性,但仅限于生发中心B细胞的表达被排除评估。
- IMP3/PAX5双阳性细胞提示IVLBCL可能。
临床怎么用
- 对于疑似IVLBCL的病例,可采用IMP3免疫组化辅助诊断,尤其当常规诊断困难时。
- IMP3/PAX5双染可提高对血管内B细胞增殖的识别能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of aggressive extranodal large B-cell lymphoma characterized by the selective growth of lymphoma cells within the lumina of blood vessels, particularly capillaries. IVLBCL lacks mass formation, and its diagnosis can be challenging. We analyzed the utility of insulin-like growth factor II mRNA-binding protein 3 (IMP3) immunohistochemistry for IVLBCL diagnosis in various organs. Double staining with paired box 5 (PAX5) was performed for validation. Overall, 152 pathological specimens (111 positive and 41 negative for IVLBCL) obtained from 88 patients with a diagnosis of IVLBCL were stained for IMP3 and IMP3/PAX5. As negative controls, 40 pathology specimens from 38 patients with no history of IVLBCL or other B-cell lymphomas were stained for IMP3, which comprised 31 benign pathological specimens from 29 patients in whom malignancy was suspected, 7 cases of appendicitis with intravascular and/or intralymphatic lymphoid proliferations, and 2 cases of intravascular natural killer/T-cell lymphoma. All mononuclear cells with cytoplasmic staining were considered positive for IMP3 expression, but expression restricted to germinal center B cells was excluded from evaluation. All 111 IVLBCL pathological specimens were positive for IMP3 and IMP3/PAX5. In addition, 11 of the 41 specimens originally diagnosed as IVLBCL-negative showed IMP3/PAX5 double-positive cells, raising the suspicion of IVLBCL. However, of the 40 negative control samples, IMP3-positive non-germinal center B cells were detected in only 2 samples ( P = 0.0131) and no intravascular IMP3-positive B cells suspicious for IVLBCL were identified. Altogether, IMP3 immunohistochemistry is a highly sensitive marker of IVLBCL and can be a helpful adjunct for IVLBCL diagnosis.
引用
- Saka M, Fujimoto M, Mizoguchi K, et al. Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients. Am J Surg Pathol. 2024. PMID: 38497417. doi:10.1097/PAS.0000000000002214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。